Skip to content

Drug interactions

Ethosuximide + Tecovirimat

Severity: Minor

Ethosuximide and Tecovirimat: minor interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Tecovirimat is a weak inducer of CYP3A4 and may modestly lower ethosuximide exposure, since ethosuximide is partly cleared by CYP3A4. Reduced seizure control is possible but is not well documented.

What this interaction means in plain words

Ethosuximide and Tecovirimat have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised.

Ethosuximide belongs to Central Nervous System; Tecovirimat belongs to Miscellaneous.

Evidence level: Low

Why it happens

Weak induction of CYP3A4 by tecovirimat increases the metabolic clearance of ethosuximide.

What to do

Watch for loss of seizure control during and after a tecovirimat course. Check ethosuximide levels if breakthrough seizures occur.

What to ask your pharmacist

  • Is there anything I should notice while taking both?
  • Do I need to tell my doctor at the next visit?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Ethosuximide and Tecovirimat, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Ethosuximide with Tecovirimat?

MediHelp rates the interaction as minor. Ethosuximide and Tecovirimat have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised. Tecovirimat is a weak inducer of CYP3A4 and may modestly lower ethosuximide exposure, since ethosuximide is partly cleared by CYP3A4. Reduced seizure control is possible but is not well documented.

How serious is the interaction between Ethosuximide and Tecovirimat?

MediHelp rates it minor, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Watch for loss of seizure control during and after a tecovirimat course. Check ethosuximide levels if breakthrough seizures occur.

What other medicines interact with Ethosuximide?

MediHelp also lists interactions of Ethosuximide with, for example, Benzhydrocodone / acetaminophen, Buprenorphine long-acting, Buprenorphine subdermal implant. The full list is on the Ethosuximide page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in